Nissan North America, Inc.
Summary
NHTSA campaign 22V772: Nissan North America, Inc. recalled for a safety defect. An inoperative rearview camera display reduces the driver's rear visibility, increasing the risk of a crash.
Details
Source
nhtsa
External ID
22V772
Action Date
2022-10-14
Status
Ongoing
Category
vehicle
Product Description
Nissan North America, Inc. (Nissan) is recalling certain 2022 Titan, Titan XD, Frontier, and 2021-2022 Rogue vehicles. The in-vehicle infotainment (IVI) system may continuously reboot when the vehicle is restarted, which can result in an inoperative rearview display. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 111, "Rear Visibility."
Company
Context & Analysis
Nissan North America, Inc. has 85 FDA actions in our database.
Frequently Asked Questions
How often does Nissan North America, Inc. have FDA actions?
Nissan North America, Inc. has 85 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle